Actively Recruiting

Phase Not Applicable
Age: 25Years +
All Genders
ID05224986

Lifestyle Patterns and Glycemic Control in Adults with Pre-diabetes

Led by Columbia University · Updated on 2026-01-28

34

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

Sponsors

C

Columbia University

Lead Sponsor

D

Department of Health and Human Services

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating whether stabilizing lifestyle behaviors can help improve blood sugar control and body composition in adults with pre-diabetes. The study aims to see if keeping consistent habits affects glucose levels and liver fat, which could influence future clinical care for many adults with pre-diabetes. Participants will be randomly assigned to one of two groups: one group will continue their usual lifestyle habits for 12 weeks, while the other group will work to stabilize their lifestyle behaviors for the same period. Before the 12-week study period, all participants will track their sleep for two weeks and wear a glucose monitor. At the beginning and end of the 12 weeks, they will undergo a glucose tolerance test and have MRI scans to assess body composition and liver fat. During the study, participants will be monitored through various tests including glucose area under the curve, adipose tissue measurements, and liver fat content. Researchers will also measure changes in blood sugar control and inflammation markers. The study lasts about 14 weeks, including the initial sleep tracking, followed by the 12-week lifestyle period and final assessments.

CONDITIONS

Brief Title

Lifestyle Patterns and Glycemic Control

Who Can Participate

Age: 25Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 25 years or older
  • Diagnosed with pre-diabetes (hemoglobin A1c 5.7-6.9%)
  • Body mass index (BMI) between 25 and 39.9 kg/m2
  • Sleep duration of at least 6 hours per night, measured by wrist actigraphy for 14 nights
  • Variable bedtime with a standard deviation of 45 minutes or more
Not Eligible

You will not qualify if you...

  • Chronic kidney disease with GFR less than 60
  • Uncontrolled high blood pressure (160/100 mmHg or higher)
  • Obstructive sleep apnea
  • Psychiatric or neurological disorders
  • Existing cardiovascular disease
  • High triglycerides (200 mg/dL or higher)
  • Use of medications affecting insulin sensitivity, glucose levels, or body weight
  • Non-day or rotating shift work
  • Recent travel across time zones
  • Active participation in a weight loss program currently or within the past 3 months
  • Current or past alcohol or drug abuse

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) to confirm eligibility and baseline measurements

Baseline Assessment

Duration - 2 weeks

Participants track their sleep and wear a glucose monitor to measure glucose levels before the intervention period. They also undergo glucose tolerance testing and MRI scans to assess body composition and liver fat content.

1 visit at the start for glucose tolerance test and MRI scanning

Outpatient Treatment

Duration - 12 weeks

Participants are randomized to either maintain their usual lifestyle habits or stabilize their behaviors for 12 weeks.

Weekly visits for monitoring and support throughout the 12-week period

Follow-up Assessments

Duration - 1 week

At the end of the 12-week period, participants undergo repeat glucose tolerance testing and MRI scans to assess changes in glucose control and body composition.

1 visit (in-person) for final assessments

Trial Site Locations

Total: 1 location

1

Columbia University Irving Medical Center

New York, New York, United States, 10032

Actively Recruiting

Loading map...

Research Team

M

Marie-Pierre St-Onge

L

Lena Navarro

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Similar Trials

A Randomized Study Comparing a Healthy Beef-Centric Diet to ...

Metabolic Syndrome (MetS)

Actively Recruiting

1 location

Continuous Glucose Monitoring (CGM) in Prediabetes: A Mixed-...

Pre-diabetes

Actively Recruiting

2 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here